Avondale Wealth Management boosted its stake in The Procter & Gamble Company (NYSE:PG – Free Report) by 64.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,200 shares of the company’s stock after purchasing an additional 1,250 shares during the quarter. Avondale Wealth Management’s holdings in Procter & Gamble were worth $536,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in PG. Itau Unibanco Holding S.A. bought a new stake in shares of Procter & Gamble in the 2nd quarter valued at approximately $28,000. Fairway Wealth LLC bought a new stake in Procter & Gamble in the second quarter worth $29,000. RPg Family Wealth Advisory LLC purchased a new position in Procter & Gamble during the third quarter worth $33,000. Quest Partners LLC bought a new position in Procter & Gamble during the second quarter valued at $36,000. Finally, Fairfield Financial Advisors LTD purchased a new stake in shares of Procter & Gamble in the second quarter valued at $44,000. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Down 1.9 %
Shares of Procter & Gamble stock traded down $3.02 during trading on Friday, reaching $159.08. The company’s stock had a trading volume of 2,088,363 shares, compared to its average volume of 5,779,391. The company has a 50-day simple moving average of $169.77 and a two-hundred day simple moving average of $169.64. The Procter & Gamble Company has a 1-year low of $146.28 and a 1-year high of $180.43. The company has a market cap of $374.64 billion, a price-to-earnings ratio of 27.43, a P/E/G ratio of 3.70 and a beta of 0.45. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50.
Insider Transactions at Procter & Gamble
In other news, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the sale, the chief executive officer now owns 39,977 shares in the company, valued at $7,189,463.68. This represents a 54.48 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO R. Alexandra Keith sold 1,992 shares of Procter & Gamble stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the transaction, the chief executive officer now owns 13,783 shares of the company’s stock, valued at $2,343,110. The trade was a 12.63 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 75,439 shares of company stock worth $13,317,460. Company insiders own 0.18% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on the stock. DA Davidson reiterated a “buy” rating and set a $209.00 price target on shares of Procter & Gamble in a report on Friday, December 27th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $164.00 price target on shares of Procter & Gamble in a report on Monday, October 21st. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. Evercore ISI raised their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Eight investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $179.75.
Read Our Latest Stock Report on PG
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- What Are the FAANG Stocks and Are They Good Investments?
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- P/E Ratio Calculation: How to Assess Stocks
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 3 EV Stocks Offering Unique Alternatives to Tesla
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.